Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	63.4	51.37	31.17	73.98	50.71	71.72
Short-Term Investments	18.15	22.41	73.94	22.52	106.51	151.16
Cash & Short-Term Investments	81.55	73.78	105.11	96.5	157.22	222.88
Cash Growth	14.24%	-29.81%	8.92%	-38.62%	-29.46%	247.39%
Accounts Receivable	40.63	34.1	12.1	-	-	-
Other Receivables	-	-	-	2.25	31.54	38.44
Receivables	40.63	34.1	12.1	2.25	31.54	38.44
Inventory	23.48	20.3	10.38	-	-	-
Prepaid Expenses	12.67	5.15	4.37	1.52	3.18	1.02
Other Current Assets	0.77	0.88	2.24	0.57	0.55	1.12
Total Current Assets	159.11	134.21	134.2	100.84	192.49	263.45
Property, Plant & Equipment	11.01	12.86	13.08	13.24	11.49	8.16
Goodwill	16.84	16.84	16.84	16.84	16.84	16.84
Long-Term Deferred Tax Assets	-	-	-	-	24.13	18.26
Other Long-Term Assets	0.21	0.34	0.58	1.87	2.33	4.93
Total Assets	187.16	164.24	164.7	132.79	247.27	311.64
Accounts Payable	10.11	7.33	11.43	7.89	7.68	2.93
Accrued Expenses	28.25	24.54	19.45	8.51	12.03	8.68
Current Portion of Long-Term Debt	-	1.89	0.73	37.67	-	-
Current Portion of Leases	0.72	0.58	0.93	0.96	0.9	0.47
Other Current Liabilities	17.98	14.49	4.31	0.77	0.39	3.03
Total Current Liabilities	57.07	48.83	36.86	55.79	21	15.11
Long-Term Debt	35.32	35.25	32.76	91.61	142.4	128.21
Long-Term Leases	2	1.12	1.69	0.78	1.71	1.84
Other Long-Term Liabilities	2.06	5.18	5.65	5.74	3.92	4.21
Total Liabilities	96.45	90.39	76.96	153.93	169.02	149.37
Common Stock	0.97	0.97	0.9	0.63	0.59	0.58
Additional Paid-In Capital	902.97	891.79	855.45	589.78	549.35	566.92
Retained Earnings	-789.58	-794.33	-745.5	-585.22	-447.76	-384.19
Comprehensive Income & Other	-23.65	-24.58	-23.17	-26.34	-23.94	-21.05
Total Common Equity	90.71	73.85	87.69	-21.15	78.24	162.26
Shareholders' Equity	90.71	73.85	87.74	-21.15	78.24	162.27
Total Liabilities & Equity	187.16	164.24	164.7	132.79	247.27	311.64
Total Debt	38.04	38.84	36.11	131.02	145	130.52
Net Cash (Debt)	43.5	34.93	69	-34.52	12.22	92.36
Net Cash Growth	35.28%	-49.37%	-	-	-86.77%	-
Net Cash Per Share	0.45	0.37	0.86	-0.57	0.21	1.68
Filing Date Shares Outstanding	97.1	96.63	90.58	64.48	59.03	58.47
Total Common Shares Outstanding	96.78	96.52	89.83	62.88	58.62	58.4
Working Capital	102.04	85.37	97.35	45.05	171.49	248.35
Book Value Per Share	0.94	0.77	0.98	-0.34	1.33	2.78
Tangible Book Value	73.87	57.01	70.85	-37.99	61.4	145.43
Tangible Book Value Per Share	0.76	0.59	0.79	-0.60	1.05	2.49
Machinery	-	0.63	0.63	0.63	0.3	0.3

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q